Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

Hypertension in the elderly

Nicolas R Robles, Juan F Macias1

  • 1Unidad de Hipertension Arterial, Hospital Infanta Cristina, Carretera de Portugal s/n. 06080, Badajoz, Spain. nrrobles@yahoo.es.

Cardiovascular & Hematological Agents in Medicinal Chemistry
|March 12, 2015
PubMed

Insights

Hypertension prevalence increases with age, posing risks for older adults. Managing high blood pressure (HBP) in the elderly is complex, requiring careful consideration of treatment strategies.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Hypertension prevalence significantly increases with age.
  • High blood pressure (HBP) is a major risk factor for cardiovascular, cerebrovascular, and renal diseases, especially in the elderly.
  • Managing hypertension in older adults presents a clinical challenge due to physiological changes and potential comorbidities.

Purpose of the Study:

  • To review the pathophysiology of aging related to hypertension.
  • To examine the epidemiology of high blood pressure in older populations.
  • To discuss the clinical assessment and management dilemmas of hypertension in the elderly.

Main Methods:

  • Review of 30-year data on hypertension prevalence.
  • Analysis of aging-related physiological changes impacting blood pressure.
  • Synthesis of current clinical guidelines and research on elderly hypertension management.

Main Results:

  • Aging is associated with increased physiological decline and susceptibility to diseases like hypertension.
  • Elderly hypertension requires careful management to mitigate risks of serious health complications.
  • Treatment strategies for hypertension in older adults are complex and require individualized approaches.

Conclusions:

  • Understanding the aging process is crucial for managing hypertension in older adults.
  • Effective control of HBP in the elderly is vital for reducing morbidity and mortality.
  • Further research is needed to optimize treatment protocols for geriatric hypertension.

More Related Videos

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
374
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.3K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
343
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
331
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
353